DaVita
DVA
#1887
Rank
C$14.35 B
Marketcap
C$214.72
Share price
-0.19%
Change (1 day)
-1.90%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$14.03

According to DaVita's latest financial reports the company's current EPS (TTM) is C$14.10. In 2024 the company made an earnings per share (EPS) of C$15.37 an increase over its 2023 EPS that were of C$10.60.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.03-8.72%
2024C$15.3744.94%
2023C$10.6027.26%
2022C$8.33-35.56%
2021C$12.9344.1%
2020C$8.9719.7%
2019C$7.50540.48%
2018C$1.17-76.07%
2017C$4.89-19.31%
2016C$6.06242.52%
2015C$1.77-62.87%
2014C$4.7613.43%
2013C$4.208.45%
2012C$3.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$32.70 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$14.67 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$20.48 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.65-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA